# FDA recall D-600-2013

> **OLAAX International** · Class I · drug recall initiated 2013-02-12.

## Product

MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL

## Reason for recall

Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.

## Distribution

Nationwide, Puerto Rico and  Venezuela and Bolivia

## Key facts

- **Recall number:** D-600-2013
- **Recalling firm:** OLAAX International
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-02-12
- **Report date:** 2013-06-19
- **Termination date:** 2019-10-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bartow, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-600-2013

## Citation

> AI Analytics. FDA recall D-600-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-600-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*